Mind + Muscle

technical minds + legal muscle


dig deep

The Federal Circuit Expands Obviousness-Type Double Patenting in Gilead v. Natco.

  • 07.15.14
  • Gaby L. Longsworth, Ph.D., Eric K. Steffe, and Marsha Rose Gillentine
  • MSBA Annual IP Law Update 2014

In this article, Gaby L. Longsworth, Ph.D., Eric K. Steffe, and Marsha Rose Gillentine, Ph.D. outline the consequences of the recent Federal Circuit ruling in Gilead Sciences v. Natco Pharma. The authors note that this ruling "adds another layer of complexity to the already-complicated law of obviousness-type double patenting (ODP)." They discuss the patents at issue in the case, provide an overview of litigation, and highlight the implications for the biotechnology and pharmaceutical industries.  

To read the full article, please download the attached PDF and visit pages 20-22.

Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.